Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hep.30545 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, Status, and Clinical Implications.
J Clin Oncol
March 2025
Anna Fagotti, MD, PhD and Rita Trozzi, MD, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy, Università Cattolica del Sacro Cuore, Rome, Italy; Diana Giannarelli, PhD, MSc, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy; and Giovanni Scambia, MD, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy, Università Cattolica del Sacro Cuore, Rome, Italy.
Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, Status, and Clinical Implications.
J Clin Oncol
March 2025
Gini F. Fleming, MD, The University of Chicago, Chicago, IL.
[Retracted] MicroRNA‑132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma.
Int J Mol Med
May 2025
Department of Neurosurgery, Linyi People's Hospital, Linyi, Shandong 276000, P.R. China.
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the clonogenic agar assay data shown in Fig. 5C on p. 1312 were strikingly similar to data appearing in different form in another article written by different authors at different research institutes, which had already been published in the journal prior to the submission of this paper to International Journal of Molecular Medicine.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!